Sometimes were haggling over doses, says Dushay, who wrote about this topic in an op-ed for STAT in February
The only difference between Wegovy and Ozempic is the available dose, with Wegovy available up to 2.4 mg, compared to 1 mg with Ozempic
However, both interactions differed in the case of mitochondria, where in resistant plants against PVY NTN , deposition generally remained unchanged, while Arabidopsis plants resistant to TuMV exhibited induced deposition in this organelle
From a clinical standpoint, the message is clear: - Yes to metabolic monitoring - Yes to awareness of glycemic risk - But no to avoiding statins out of fear of diabetes, especially in patients at high cardiovascular risk The real question isnt: Do statins cause diabetes? but rather: Does cardiovascular benefit outweigh metabolic risk? And once again, the answer is: yes
Maybe, but do not count on it at launch